Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Long-term Therapy With Piribedil (CLARIUM) in Patients With M. Parkinson Under Consideration of Quality of Life Parameters and Cognitive Function

NCT01519856 is registered in ClinicalTrials.gov with Desitin Arzneimittel GmbH as lead sponsor.

NCT NCT01519856
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01519856 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Long-term Therapy With Piribedil (CLARIUM) in Patients With M. Parkinson Under Consideration of Quality of Life Parameters and Cognitive Function
Lead sponsor
Desitin Arzneimittel GmbH
Phase
Observational
Overall status
Completed
Start date
June 30, 2009
Completion date
February 28, 2015
Enrollment
908 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

parkinson's disease